Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Other inclusion and exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
315 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Email contact via H. Lundbeck A/S
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal